Accéder au contenu
Merck

Defective regulation of the ubiquitin/proteasome system in the hypothalamus of obese male mice.

Endocrinology (2014-06-04)
Leticia M Ignacio-Souza, Bruna Bombassaro, Livia B Pascoal, Mariana A Portovedo, Daniela S Razolli, Andressa Coope, Sheila C Victorio, Rodrigo F de Moura, Lucas F Nascimento, Ana P Arruda, Gabriel F Anhe, Marciane Milanski, Licio A Velloso
RÉSUMÉ

In both human and experimental obesity, inflammatory damage to the hypothalamus plays an important role in the loss of the coordinated control of food intake and energy expenditure. Upon prolonged maintenance of increased body mass, the brain changes the defended set point of adiposity, and returning to normal weight becomes extremely difficult. Here we show that in prolonged but not in short-term obesity, the ubiquitin/proteasome system in the hypothalamus fails to maintain an adequate rate of protein recycling, leading to the accumulation of ubiquitinated proteins. This is accompanied by an increased colocalization of ubiquitin and p62 in the arcuate nucleus and reduced expression of autophagy markers in the hypothalamus. Genetic protection from obesity is accompanied by the normal regulation of the ubiquitin/proteasome system in the hypothalamus, whereas the inhibition of proteasome or p62 results in the acceleration of body mass gain in mice exposed for a short period to a high-fat diet. Thus, the defective regulation of the ubiquitin/proteasome system in the hypothalamus may be an important mechanism involved in the progression and autoperpetuation of obesity.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
MISSION® esiRNA, targeting mouse Gtf2h1
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Dctn4
Sigma-Aldrich
MISSION® esiRNA, targeting human DCTN4
Sigma-Aldrich
MISSION® esiRNA, targeting human GTF2H1